CVE-2024-48890: An improper neutralization of special elements used in an OS command ('OS Command Injection') vulnerability [C
CVE-2024-48890 is a medium-severity flaw (CVSS 6.6) affecting fortisoar imap connector. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
An improper neutralization of special elements used in an OS command ('OS Command Injection') vulnerability [CWE-78] in FortiSOAR IMAP connector version 3.5.7 and below may allow an authenticated attacker to execute unauthorized code or commands via a specifically crafted playbook
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 6.6 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | High |
| User interaction | None |
| EPSS exploit chance | 1.2% (top 33%) |
| CISA exploited list | No |
| Weakness | CWE-78 |
| Published | 2025-01-14 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2024-48890?
fortisoar imap connector: upgrade to 3.5.8. Exact commands for each OS are on this page.
Is CVE-2024-48890 being exploited?
CVE-2024-48890 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2024-48890 affect?
CVE-2024-48890 affects fortisoar imap connector. Severity is medium (CVSS 6.6). An improper neutralization of special elements used in an OS command ('OS Command Injection') vulnerability [CWE-78] in FortiSOAR IMAP connector version 3.5.7 and below may allow an authenticated attacker to execute unauthorized code or com
How urgent is CVE-2024-48890?
Priority 40/100. No elevated risk signals yet.